Frec Markets’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Frec Markets's VRTX Position: Q3 2026 in Review
Frec Markets increased its Vertex Pharmaceuticals (VRTX) stake by 38% in Q3 2026, buying an estimated $536K and bringing the position to 3,825 shares worth $2M. The position accounts for 0.13% of the portfolio, ranked #147.
Frec Markets first reported a position in VRTX in Q4 2025 and has held it in 4 quarters since. 1,798 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Frec Markets held 3,825 shares of Vertex Pharmaceuticals worth $2M as of Q3 2026.
- Frec Markets bought 1,047 Vertex Pharmaceuticals shares in Q3 2026, an estimated $536K.
- Vertex Pharmaceuticals made up 0.13% of Frec Markets's portfolio in Q3 2026, its #147 holding.
- Frec Markets first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
- 1,798 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Frec Markets's 13F filing for Q3 2026, filed 16 Nov 2026.